Dr. Salvatore Rosanio, MD

Dr. Rosanio practices at Pacific Cardiovascular Associates Medical Group, Inc. in Costa Mesa, California.

Dr. Rosanio's NPI, 1245399740, was assigned on December 8, 2006. Dr. Rosanio holds California license C55461.

Dr. Rosanio's primary practice is Pacific Cardiovascular Associates Medical Group, Inc., at 3070 Bristol St, Costa Mesa, CA 92626 in Orange County. The practice phone is (714) 445-0220.

Dr. Rosanio's primary practice is Pacific Cardiovascular Associates Medical Group, Inc. in Costa Mesa, California. Dr. Rosanio is also affiliated with Providence Mission Hospital. The medical group on file is Pacific Cardiovascular Associates (PCA) Medical Group. Dmand AI also links Dr. Rosanio to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosanio practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rosanio's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Rosanio's licenses on file in 2 states: California and Texas.

CMS data shows 752 Medicare services from Dr. Rosanio across 7 procedure codes in 2024, for 478 Medicare patients. Medicare paid $39,951 for them.

CMS counts 478 Medicare patients who saw Dr. Rosanio in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosanio's median patient age at 63, with 52% women.

In 2024, Dr. Rosanio wrote 698 Medicare Part D claims for 226 patients. 84% of them were for generic drugs. CMS names the drug for 589 of them, across 15 drugs with 11 or more claims each, at $103,860 in total drug cost. In 2023, CMS named 873 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rosanio for performance year 2024, reported as part of a group. Dr. Rosanio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Rosanio, published from 2011 to 2016. 2014 was the busiest year, with 2. The most frequent topics are Anticoagulants and Atrial Fibrillation. Dr. Rosanio has published most often in Int J Cardiol. Dr. Rosanio's most frequent co-authors are Abdul Moez Keylani, FACC, MD, Darrin C. D'Agostino, DO and Ernst R. Schwarz, MD.

CMS Open Payments shows 340 general payments to Dr. Rosanio from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $830.